Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10121 | 31474792 | Ann Gastroenterol | High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy. | 2019 | Details |
| A10122 | 31474685 | J Nutr Sci Vitaminol (Tokyo) | Age-Related Alterations of Nonalcoholic Steatohepatitis in Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet. | 2019 | Details |
| A10124 | 31474633 | Yakugaku Zasshi | [Involvement of the Free Fatty Acid Receptor GPR120/FFAR4 in the Development of Nonalcoholic Steatohepatitis]. | 2019 | Details |
| A10125 | 31474632 | Yakugaku Zasshi | [Role of Angiogenesis and Chronic Inflammation in Fat Hypertrophy in NASH Pathology]. | 2019 | Details |
| A10133 | 31472960 | Biochem Biophys Res Commun | Knockout of neutrophil elastase protects against western diet induced nonalcoholic steatohepatitis in mice by regulating hepatic ceramides metabolism. | 2019 | Details |
| A10143 | 31470414 | Endocr Connect | Insulin resistance associates with hepatic lobular inflammation in subjects with obesity. | 2019 | Details |
| A10148 | 31469911 | Hepatology | hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis. | 2020 | Details |
| A10151 | 31467529 | Int J Endocrinol | Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-κB Pathway. | 2019 | Details |
| A10196 | 31438528 | Mar Drugs | Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation. | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10205 | 31433301 | J Hepatol | Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. | 2019 | Details |
| A10210 | 31430977 | Int J Mol Sci | Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders. | 2019 | Details |
| A10212 | 31430456 | Eur J Pharmacol | Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells. | 2019 | Details |
| A10218 | 31426291 | Int J Mol Sci | Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. | 2019 | Details |
| A10226 | 31421545 | Int Immunopharmacol | Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice. | 2019 | Details |
| A10227 | 31421115 | Chem Biol Interact | Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner. | 2019 | Details |
| A10228 | 31421090 | Eur J Pharmacol | Iron chelators in obesity therapy - Old drugs from a new perspective? | 2019 | Details |
| A10237 | 31418509 | Phytother Res | Fiber and phenolic compounds contribution to the hepatoprotective effects of mango diets in rats fed high cholesterol/sodium cholate. | 2019 | Details |
| A10239 | 31417486 | Front Neurol | Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration. | 2019 | Details |
| A10249 | 31412267 | Eur J Pharmacol | Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways. | 2019 | Details |
| A10258 | 31408586 | Mol Nutr Food Res | Lycopene Alleviates Obesity-Induced Inflammation and Insulin Resistance by Regulating M1/M2 Status of Macrophages. | 2019 | Details |
| A10286 | 31399137 | BMC Res Notes | Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis. | 2019 | Details |
| A10293 | 31396538 | J Diabetes Res | Visfatin Induces Inflammation and Insulin Resistance via the NF-κB and STAT3 Signaling Pathways in Hepatocytes. | 2019 | Details |
| A10295 | 31394881 | Nutrients | Non-Alcoholic Fatty Liver Disease is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study. | 2019 | Details |
| A10300 | 31393787 | Am J Physiol Gastrointest Liver Physiol | Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21. | 2019 | Details |
| A10306 | 31391765 | World J Gastroenterol | Importance of fatigue and its measurement in chronic liver disease. | 2019 | Details |
| A10310 | 31390551 | Cell Metab | Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism. | 2019 | Details |
| A10316 | 31388695 | Diabetologia | Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis. | 2019 | Details |
| A10325 | 31387306 | Int J Mol Sci | High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD. | 2019 | Details |
| A10330 | 31387054 | Phytomedicine | The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease. | 2019 | Details |
| A10339 | 31384519 | Biosci Microbiota Food Health | The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. | 2019 | Details |
| A10367 | 31372694 | Naunyn Schmiedebergs Arch Pharmacol | Chrysin ameliorates nonalcoholic fatty liver disease in rats. | 2019 | Details |
| A10379 | 31364723 | Int J Mol Med | Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats. | 2019 | Details |
| A10384 | 31361524 | FASEB J | Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway. | 2019 | Details |
| A10385 | 31361003 | Nutr Rev | Effect of dietary intervention, with or without co-interventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic literature review. | 2019 | Details |
| A10387 | 31360022 | J Clin Exp Hepatol | The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation. | 2018 | Details |
| A10392 | 31357780 | Zhonghua Gan Zang Bing Za Zhi | [A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis]. | 2019 | Details |
| A10395 | 31356989 | Biochim Biophys Acta Gene Regul Mech | An interaction between MKL1, BRG1, and C/EBPβ mediates palmitate induced CRP transcription in hepatocytes. | 2019 | Details |
| A10397 | 31355570 | Zhongguo Zhong Yao Za Zhi | [Psoralen and isopsoralen improve lipid metabolism disorder via inhibition of NF-κB activation in LO2 cells]. | 2019 | Details |
| A10400 | 31354322 | Diabetes Metab Syndr Obes | Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women. | 2019 | Details |
| A10406 | 31351021 | Diabetes Metab Res Rev | C-peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetes. | 2019 | Details |
| A10408 | 31349549 | J Clin Med | Nutrition in Gastrointestinal Disease: Liver, Pancreatic, and Inflammatory Bowel Disease. | 2019 | Details |
| A10413 | 31345778 | Lancet Gastroenterol Hepatol | Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial. | 2019 | Details |
| A10415 | 31345163 | BMC Gastroenterol | Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. | 2019 | Details |
| A10433 | 31337855 | Sci Rep | Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. | 2019 | Details |
| A10444 | 31334554 | J Nutr | A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk. | 2019 | Details |
| A10458 | 31328113 | Prev Nutr Food Sci | Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10463 | 31325892 | J Nutr Biochem | Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways. | 2019 | Details |
| A10465 | 31325638 | Biochim Biophys Acta Mol Cell Biol Lipids | Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH. | 2019 | Details |
| A10467 | 31324878 | Int J Obes (Lond) | Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats. | 2019 | Details |
| A10474 | 31322255 | Mol Med Rep | Adenovirus‑mediated overexpression of bone morphogenetic protein‑9 promotes methionine choline deficiency‑induced non‑alcoholic steatohepatitis in non‑obese mice. | 2019 | Details |
| A10475 | 31322211 | Mol Med Rep | Ascorbic acid attenuates cell stress by activating the fibroblast growth factor 21/fibroblast growth factor receptor 2/adiponectin pathway in HepG2 cells. | 2019 | Details |
| A10495 | 31311491 | BMC Gastroenterol | Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. | 2019 | Details |
| A10496 | 31311339 | Arch Physiol Biochem | The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model. | 2019 | Details |
| A10516 | 31306673 | Toxicol Appl Pharmacol | Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis. | 2019 | Details |
| A10532 | 31299271 | Toxicol Appl Pharmacol | IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A10536 | 31297627 | Dig Dis Sci | A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. | 2019 | Details |
| A10545 | 31293441 | Front Physiol | The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH). | 2019 | Details |
| A10546 | 31293341 | World J Gastroenterol | Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease. | 2019 | Details |
| A10551 | 31292564 | Nat Rev Rheumatol | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. | 2019 | Details |
| A10557 | 31291245 | PLoS One | Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. | 2019 | Details |
| A10561 | 31290733 | J Med Food | The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study. | 2019 | Details |
| A10567 | 31288346 | Zhonghua Yu Fang Yi Xue Za Zhi | [Childhood obesity and early target organ damage]. | 2019 | Details |
| A10568 | 31288283 | Z Gastroenterol | [Microbiome & NASH - partners in crime driving progression of fatty liver disease]. | 2019 | Details |
| A10573 | 31284229 | Int Immunopharmacol | Activation of hepatic iNKT2 cells by α-GalCer ameliorates hepatic steatosis induced by high-fat diet in C57BL/6J mice. | 2019 | Details |
| A10574 | 31283861 | Oral Dis | Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways. | 2019 | Details |
| A10589 | 31279739 | Metabolism | Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. | 2019 | Details |
| A10599 | 31275421 | Evid Based Complement Alternat Med | The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats. | 2019 | Details |
| A10601 | 31275407 | Evid Based Complement Alternat Med | Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review. | 2019 | Details |
| A10607 | 31273617 | Hepatol Int | Hepatology through the crystal ball. | 2019 | Details |
| A10617 | 31269941 | BMC Complement Altern Med | Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks. | 2019 | Details |
| A10624 | 31266632 | Biochem Biophys Res Commun | Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. | 2019 | Details |
| A10628 | 31264313 | Phytother Res | Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial. | 2019 | Details |
| A10630 | 31263038 | J Immunol | Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages. | 2019 | Details |
| A10635 | 31260574 | J Eur Acad Dermatol Venereol | High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors. | 2019 | Details |
| A10639 | 31258620 | Therap Adv Gastroenterol | The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. | 2019 | Details |
| A10647 | 31255652 | Gastroenterology | Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10651 | 31254236 | Clin Rheumatol | Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients. | 2019 | Details |
| A10669 | 31244392 | Biosci Biotechnol Biochem | Extracts of bilberry (Vaccinium myrtillus L.) fruits improve liver steatosis and injury in mice by preventing lipid accumulation and cell death. | 2019 | Details |
| A10684 | 31236937 | Australas J Dermatol | Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk. | 2019 | Details |
| A10691 | 31235092 | Diabetes Metab Syndr | Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. | 2019 | Details |
| A10701 | 31230380 | Hepatology | The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10726 | 31219825 | Curr Opin Clin Nutr Metab Care | Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions? | 2019 | Details |
| A10733 | 31217465 | Sci Rep | Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10738 | 31215262 | Expert Rev Gastroenterol Hepatol | Olive oil antioxidants and non-alcoholic fatty liver disease. | 2019 | Details |
| A10740 | 31214277 | Oxid Med Cell Longev | TNFα-Mediated Necroptosis Aggravates Ischemia-Reperfusion Injury in the Fatty Liver by Regulating the Inflammatory Response. | 2019 | Details |
| A10748 | 31212314 | J Nutr | Dietary β-Cryptoxanthin Inhibits High-Refined Carbohydrate Diet-Induced Fatty Liver via Differential Protective Mechanisms Depending on Carotenoid Cleavage Enzymes in Male Mice. | 2019 | Details |
| A10750 | 31211018 | PeerJ | Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. | 2019 | Details |
| A10754 | 31209199 | Cell Death Dis | Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. | 2019 | Details |
| A10759 | 31207429 | Pharmacol Rep | Protection against nonalcoholic steatohepatitis through targeting IL-18 and IL-1alpha by luteolin. | 2019 | Details |
| A10761 | 31206703 | J Physiol | Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance. | 2019 | Details |
| A10762 | 31205454 | Dose Response | Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose Tissue. | 2019 | Details |
| A10763 | 31204416 | J Gastrointestin Liver Dis | Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | 2019 | Details |
| A10786 | 31193303 | J Adv Res | Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review. | 2018 | Details |
| A10790 | 31191550 | Front Immunol | Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10791 | 31191364 | Front Physiol | Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes. | 2019 | Details |
| A10792 | 31191323 | Front Pharmacol | Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10810 | 31177662 | Zhonghua Gan Zang Bing Za Zhi | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. | 2019 | Details |
| A10814 | 31176631 | Dig Liver Dis | Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. | 2019 | Details |
| A10822 | 31173200 | Mol Med Rep | Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice. | 2019 | Details |